D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 116 Citations 47,258 895 World Ranking 1864 National Ranking 75

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Law

His primary areas of study are Acquired immunodeficiency syndrome, Substance abuse, Psychiatry, Cohort study and Cohort. The concepts of his Acquired immunodeficiency syndrome study are interwoven with issues in Viral disease, Internal medicine and Immunology. The study incorporates disciplines such as Odds ratio, Surgery, Retrospective cohort study, Environmental health and Drug in addition to Substance abuse.

His research integrates issues of Epidemiology, Health care and Public health in his study of Psychiatry. Evan Wood combines subjects such as Sex work and Demography with his study of Cohort study. His work deals with themes such as Methadone, Gee, Heroin and Emergency medicine, which intersect with Cohort.

His most cited work include:

  • Rates of Disease Progression by Baseline CD4 Cell Count and Viral Load After Initiating Triple-Drug Therapy (658 citations)
  • Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study (651 citations)
  • Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study (651 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Psychiatry, Prospective cohort study, Odds ratio, Cohort and Acquired immunodeficiency syndrome. His Psychiatry research focuses on subjects like Public health, which are linked to Family medicine. His Prospective cohort study research incorporates themes from Incidence, Cohort study, Demography, Proportional hazards model and Hazard ratio.

His Cohort study research is multidisciplinary, incorporating elements of Young adult and Substance abuse. His Odds ratio study also includes fields such as

  • Confidence interval that connect with fields like Harm reduction,
  • Psychological intervention that intertwine with fields like Environmental health. His work in Acquired immunodeficiency syndrome tackles topics such as Surgery which are related to areas like Syringe.

He most often published in these fields:

  • Psychiatry (51.17%)
  • Prospective cohort study (39.59%)
  • Odds ratio (36.55%)

What were the highlights of his more recent work (between 2016-2021)?

  • Psychiatry (51.17%)
  • Prospective cohort study (39.59%)
  • Confidence interval (24.57%)

In recent papers he was focusing on the following fields of study:

Evan Wood mostly deals with Psychiatry, Prospective cohort study, Confidence interval, Odds ratio and Demography. His work on Addiction and Stimulant as part of general Psychiatry study is frequently connected to Opioid use disorder and Longitudinal study, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. Evan Wood interconnects Heroin, Harm reduction, Public health, Hazard ratio and Cohort in the investigation of issues within Prospective cohort study.

His studies link Acquired immunodeficiency syndrome with Public health. Evan Wood works mostly in the field of Cohort, limiting it down to topics relating to Cohort study and, in certain cases, Observational study. His study looks at the relationship between Demography and topics such as Mental health, which overlap with Community health and Substance abuse.

Between 2016 and 2021, his most popular works were:

  • Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting. (79 citations)
  • HIV and the criminalisation of drug use among people who inject drugs: a systematic review (77 citations)
  • Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: A cross-sectional urine toxicology screening study. (41 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Law

Evan Wood mainly focuses on Psychiatry, Heroin, Prospective cohort study, Demography and Harm reduction. His biological study spans a wide range of topics, including Optometry and Cohort. Heroin is the subject of his research, which falls under Drug.

His Prospective cohort study research integrates issues from Viral load, Cohort study and HIV-positive people. The various areas that he examines in his Demography study include Odds ratio, Acquired immunodeficiency syndrome and Confidence interval. His studies examine the connections between Public health and genetics, as well as such issues in Needle sharing, with regards to Incidence.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Rates of Disease Progression by Baseline CD4 Cell Count and Viral Load After Initiating Triple-Drug Therapy

Robert S. Hogg;Benita Yip;Keith J. Chan;Evan Wood.
JAMA (2001)

962 Citations

Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study

Julio S.G. Montaner;Julio S.G. Montaner;Julio S.G. Montaner;Viviane D. Lima;Viviane D. Lima;Rolando Barrios;Benita Yip.
The Lancet (2010)

897 Citations

The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic

Julio S. G. Montaner;Robert Hogg;Evan Wood;Thomas Kerr.
The Lancet (2006)

652 Citations

Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 × 109 cells/L

Evan Wood;Robert S. Hogg;Benita Yip;P. Richard Harrigan.
Annals of Internal Medicine (2003)

459 Citations

Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic.

Mark W Tyndall;Sue Currie;Patricia Spittal;Kathy Li.
AIDS (2003)

436 Citations

Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study

Evan Wood;Thomas Kerr;Brandon D L Marshall;Kathy Li.
BMJ (2009)

392 Citations

Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study.

Brandon D. L. Marshall;M.-J. Milloy;Evan Wood;Julio S. G. Montaner.
The Lancet (2011)

380 Citations

The public health and social impacts of drug market enforcement: A review of the evidence

Thomas Kerr;Thomas Kerr;Will Small;Evan Wood;Evan Wood.
International Journal of Drug Policy (2005)

347 Citations

Safer injection facility use and syringe sharing in injection drug users

Thomas Kerr;Thomas Kerr;Mark Tyndall;Mark Tyndall;Kathy Li;Kathy Li;Julio Montaner;Julio Montaner.
The Lancet (2005)

327 Citations

Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy.

Viviane D. Lima;Robert S. Hogg;P. Richard Harrigan;David Moore.
AIDS (2007)

323 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Evan Wood

Julio S. G. Montaner

Julio S. G. Montaner

University of British Columbia

Publications: 320

Robert S. Hogg

Robert S. Hogg

Simon Fraser University

Publications: 268

Thomas Kerr

Thomas Kerr

University of British Columbia

Publications: 225

Steffanie A. Strathdee

Steffanie A. Strathdee

University of California, San Diego

Publications: 177

Frederick L. Altice

Frederick L. Altice

Yale University

Publications: 134

Louisa Degenhardt

Louisa Degenhardt

University of New South Wales

Publications: 115

Benedikt Fischer

Benedikt Fischer

Federal University of Sao Paulo

Publications: 115

Kate Shannon

Kate Shannon

University of British Columbia

Publications: 110

Lisa Maher

Lisa Maher

University of New South Wales

Publications: 92

Leo Beletsky

Leo Beletsky

Northeastern University

Publications: 88

Don C. Des Jarlais

Don C. Des Jarlais

New York University

Publications: 87

Matthew Hickman

Matthew Hickman

University of Bristol

Publications: 77

Mark W. Tyndall

Mark W. Tyndall

University of British Columbia

Publications: 76

Will Small

Will Small

Simon Fraser University

Publications: 76

Margaret Hellard

Margaret Hellard

Burnet Institute

Publications: 75

Brandon D. L. Marshall

Brandon D. L. Marshall

Brown University

Publications: 73

Trending Scientists

Jinbo Xu

Jinbo Xu

Toyota Technological Institute at Chicago

Michael Strube

Michael Strube

Heidelberg Institute for Theoretical Studies

Anutosh Chakraborty

Anutosh Chakraborty

Nanyang Technological University

Donald J. Burton

Donald J. Burton

University of Iowa

Elisabeth Verpoorte

Elisabeth Verpoorte

University of Groningen

Sean Parkin

Sean Parkin

University of Kentucky

Peter R. Preiser

Peter R. Preiser

Nanyang Technological University

Kunio Yasuda

Kunio Yasuda

Nara Institute of Science and Technology

Marcelo Tabarelli

Marcelo Tabarelli

Federal University of Pernambuco

Anna Villa

Anna Villa

National Academies of Sciences, Engineering, and Medicine

Laszlo Otvos

Laszlo Otvos

Semmelweis University

James D. Spinhirne

James D. Spinhirne

Goddard Space Flight Center

Albert J. Heber

Albert J. Heber

Purdue University West Lafayette

Mervi Könönen

Mervi Könönen

University of Eastern Finland

Paolo Ghisletta

Paolo Ghisletta

University of Geneva

Ravi Dhar

Ravi Dhar

Yale University

Something went wrong. Please try again later.